Dividend, Bristol-Myers Squibb

Is Bristol-Myers Squibb Company (BMY) the Best Dividend Stock to Buy According to Billionaires?
We recently published a list of 25 Best Dividend Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best dividend stocks to buy according to billionaires.
Bristol-Myers Squibb Company declares $0.62 dividend
Bristol-Myers Squibb Company  (NYSE:BMY) declares $0.62/share quarterly dividend, in line with previous. Forward yield 4.14% Payable May 1; for shareholders of record April 4; ex-div April 4. The Board of Directors has declared a quarterly dividend of fifty cents ($0.
Bristol Myers Squibb Announces Dividend
Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-two cents ($0.62) per share on the $0.10 par value common stock of the company. The dividend is payable on May 1, 2025, to stockholders of record at the close of business on April 4, 2025.
Bristol Myers Squibb Laying Off 290 Workers In Lawrenceville
Nearly 300 employees in Lawrenceville will lose their jobs as part of a pharmaceutical company's major cost-cutting measures, officials said.Bristol Myers Squibb will lay off at least 290 employees in 2025,
Bristol-Myers Squibb Stock: A Strong Buy Amid Oncology Success
Bristol-Myers Squibb released financial results for Q4 2024. Check out why I am upgrading BMY stock's rating from 'Buy' to 'Strong Buy'.
FiercePharma18h
UPDATE: Bristol Myers' cost-savings drive claims another 280 jobs in US
As Bristol Myers Squibb rolls ahead with its plan to cut $1.5 billion in costs by the end of the year, the drugmaker is once ...
Reuters7d
Bristol-Myers Squibb Co
Bristol Myers forecasts steeper drop in 2025 revenue, shares fall Bristol Myers Squibb on Thursday said its 2025 revenue would fall more sharply than Wall Street had forecast due to generic ...
ETF Daily News7d
Bristol-Myers Squibb (NYSE:BMY) Receives Average Rating of “Hold” from Brokerages
Bristol-Myers Squibb Company Profile ( Get Free Report Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products ...
Yahoo Finance17d
Bristol Myers Squibb’s Sotyktu shows consistent safety profile in psoriasis trial
US-based pharmaceutical company Bristol Myers Squibb (BMS ... "Bristol Myers Squibb’s Sotyktu shows consistent safety profile in psoriasis trial" was originally created and published by ...
NBC New York27d
Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
Bristol Myers Squibb said it will slash $2 billion in costs by the end of 2027, expanding its ongoing cost-savings effort to chart a path toward long-term growth. The company also issued full ...